Therapeutic assessment of cytochrome C for the prevention of obesity through endothelial cell-targeted nanoparticulate system

Molecular Therapy

Volumn 21, Issue 3, 2013, Pages 533-541

  Hossen, Md Nazir ^a   Kajimoto, Kazuaki ^a   Akita, Hidetaka ^a   Hyodo, Mamoru ^a   Ishitsuka, Taichi ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 9; CHOLESTEROL; CYTOCHROME C; FATTY ACID; LEPTIN; NANOPARTICLE; PROHIBITIN; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SPECIFICITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIAL CELL TARGETED NANOPARTICULATE SYSTEM; ENZYME ACTIVATION; FAT MASS; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; MALE; MOUSE; NANOENCAPSULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OBESITY; PARTICLE SIZE; PROTEIN BLOOD LEVEL; SINGLE DRUG DOSE; TOXICITY TESTING; WEIGHT CHANGE;

MUS;

EID: 84875218436     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.256     Document Type: Article

References (35)

1. Elangbam, CS (2009). Review paper: Current strategies in the development of antiobesity drugs and their safety concerns. Vet Pathol 46: 10-24.
2. Melnikova, I and Wages, D (2006). Anti-obesity therapies. Nat Rev Drug Discov 5: 369-370.
3. Grundy, SM (1998). Multifactorial causation of obesity: implications for prevention. Am J Clin Nutr 67(suppl. 3): 563S-572S.
4. Bouloumié, A, Lolmède, K, Sengenès, C, Galitzky, J and Lafontan, M (2002). Angiogenesis in adipose tissue. Ann Endocrinol (Paris) 63(2 Pt 1): 91-95.
5. Crandall, DL, Hausman, GJ and Kral, JG (1997). A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4: 211-232.
6. Cho, CH, Koh, YJ, Han, J, Sung, HK, Jong Lee, H, Morisada, T et al. (2007). Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ Res 100: e47-e57.
7. Neels, JG, Thinnes, T and Loskutoff, DJ (2004). Angiogenesis in an in vivo model of adipose tissue development. FASEB J 18: 983-985.
8. Bråkenhielm, E, Cao, R, Gao, B, Angelin, B, Cannon, B, Parini, P et al. (2004). Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res 94: 1579-1588.
9. Rupnick, MA, Panigrahy, D, Zhang, CY, Dallabrida, SM, Lowell, BB, Langer, R et al. (2002). Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99: 10730-10735.
10. Lijnen, HR, Maquoi, E, Hansen, LB, Van Hoef, B, Frederix, L and Collen, D (2002). Matrix metalloproteinase inhibition impairs adipose tissue development in mice. Arterioscler Thromb Vasc Biol 22: 374-379.
11. Ejaz, A, Wu, D, Kwan, P and Meydani, M (2009). Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 139: 919-925.
12. Kolonin, MG, Saha, PK, Chan, L, Pasqualini, R and Arap, W (2004). Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10: 625-632.
13. Barnhart, KF, Christianson, DR, Hanley, PW, Driessen, WH, Bernacky, BJ, Baze, WB et al. (2011). A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med 3: 108ra112.
14. Kim, DH, Woods, SC and Seeley, RJ (2010). Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight. Diabetes 59: 907-915.
15. Jiang, X and Wang, X (2004). Cytochrome C-mediated apoptosis. Annu Rev Biochem 73: 87-106.
16. Liu, X, Kim, CN, Yang, J, Jemmerson, R and Wang, X (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86: 147-157.
17. Santra, S, Kaittanis, C and Perez, JM (2010). Cytochrome C encapsulating theranostic nanoparticles: a novel bifunctional system for targeted delivery of therapeutic membrane-impermeable proteins to tumors and imaging of cancer therapy. Mol Pharm 7: 1209-1222.
18. Mattson, MP and Chan, SL (2003). Calcium orchestrates apoptosis. Nat Cell Biol 5: 1041-1043.
19. Kunitomo, R, Miyauchi, Y and Inoue, M (1992). Synthesis of a cytochrome c derivative with prolonged in vivo half-life and determination of ascorbyl radicals in the circulation of the rat. J Biol Chem 267: 8732-8738.
20. Kajimoto, K, Hossen, MN, Hida, K, Ohga, N, Akita, H, Hyodo, M et al. (2010). Isolation and culture of microvascular endothelial cells from murine inguinal and epididymal adipose tissues. J Immunol Methods 357: 43-50.
21. Hossen, MN, Kajimoto, K, Akita, H, Hyodo, M, Ishitsuka, T and Harashima, H (2010). Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. J Control Release 147: 261-268.
22. Hossen, MN, Kajimoto, K, Akita, H, Hyodo, M and Harashima, H (2012). Vasculartargeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery. J Control Release 163: 101-110.
23. Allen, TM and Cullis, PR (2004). Drug delivery systems: entering the mainstream. Science 303: 1818-1822.
24. Tahara, Y, Kaneko, T, Toita, R, Yoshiyama, C, Kitaoka, T, Niidome, T et al. (2012). A novel double-coating carrier produced by solid-in-oil and solid-in-water nanodispersion technology for delivery of genes and proteins into cells. J Control Release 161: 713-721.
25. El Kirat, K and Morandat, S (2009). Cytochrome c interaction with neutral lipid membranes: influence of lipid packing and protein charges. Chem Phys Lipids 162: 17-24.
26. Green, DR and Reed, JC (1998). Mitochondria and apoptosis. Science 281: 1309-1312.
27. Hengartner, MO (2000). The biochemistry of apoptosis. Nature 407: 770-776.
28. Jürgensmeier, JM, Xie, Z, Deveraux, Q, Ellerby, L, Bredesen, D and Reed, JC (1998). Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95: 4997-5002.
29. Cao, X, Bennett, RL and May, WS (2008). c-Myc and caspase-2 are involved in activating Bax during cytotoxic drug-induced apoptosis. J Biol Chem 283: 14490-14496.
30. Rossé, T, Olivier, R, Monney, L, Rager, M, Conus, S, Fellay, I et al. (1998). Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496-499.
31. Kim, YM, An, JJ, Jin, YJ, Rhee, Y, Cha, BS, Lee, HC et al. (2007). Assessment of the antiobesity effects of the TNP-470 analog, CKD-732. J Mol Endocrinol 38: 455-465.
32. Cao, R, Brakenhielm, E, Wahlestedt, C, Thyberg, J and Cao, Y (2001). Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 98: 6390-6395.
33. van Kruijsdijk, RC, van der Wall, E and Visseren, FL (2009). Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 18: 2569-2578.
34. Xu, H, Barnes, GT, Yang, Q, Tan, G, Yang, D, Chou, CJ et al. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
35. Brown, RE, Jarvis, KL and Hyland, KJ (1989). Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem 180: 136-139.